Fibrobiologics Inc (FBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 13,985 | 9,163 | 2,266 | 407 |
| Receivables | N/A | N/A | 300 | N/A |
| Other current assets | 18 | 16 | 30 | 24 |
| TOTAL | $14,228 | $9,215 | $2,625 | $468 |
| Non-Current Assets | ||||
| PPE Net | 824 | 797 | N/A | N/A |
| Other Non-Current Assets | 1,393 | 1,809 | 2,199 | 0 |
| TOTAL | $2,217 | $2,606 | $2,199 | $N/A |
| Total Assets | $16,445 | $11,821 | $4,824 | $468 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 2,697 | 1,444 | 758 | 233 |
| Other current liabilities | 460 | 7,236 | 538 | N/A |
| TOTAL | $12,726 | $9,183 | $7,073 | $1,758 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 984 | 1,385 | 1,747 | 0 |
| TOTAL | $984 | $1,385 | $1,747 | $N/A |
| Total Liabilities | $13,710 | $10,568 | $8,820 | $1,758 |
| Shareholders' Equity | ||||
| Shares Outstanding, K | 37,735 | N/A | N/A | N/A |
| Common Shares | N/A | 1 | 1 | N/A |
| Retained earnings | -35,518 | -24,357 | -7,872 | -2,751 |
| Other shareholders' equity | 0 | 0 | 1,461 | 1,461 |
| TOTAL | $2,735 | $1,253 | $-3,996 | $-1,290 |
| Total Liabilities And Equity | $16,445 | $11,821 | $4,824 | $468 |